On August 3, Givaudan announced on its official website that it has completed the acquisition of Alderys, a French flavor, fragrance and cosmetic raw material biotechnology company.
Founded in 2009, Alderys is a French biotechnology company headquartered in Orsay and currently has 30 employees. The company is committed to developing innovative bioengineering approaches to produce high-value compounds from renewable raw materials. Its research and development projects aim to serve the chemical, cosmetics and nutrition industries. Alderys is well-recognized in the industry due to its innovative technological industrial solutions reaching high sustainability standards.
Givaudan Fragrance Division President Maurizio Volpi (Maurizio Volpi) said: Their biotechnology expertise fits perfectly with our fragrance and active beauty business. Thanks to their powerful bioengineering research and development platform, we can expand the natural and biological product portfolio.
Alderys CEO Dominique Thomas expressed pride in joining Givaudan and emphasized that the company will continue to serve new and existing customers as an independent entity in the Givaudan family.
Although the terms of the transaction were not disclosed, on an assumption, Alderys' business could add 3 million Euros to Givaudan's performance in 2019.
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Simcere wins 3 billion large varieties, Roche 60% of the market is in danger
The global cosmetics chemicals market will reach $27.73 billion in 2025
Minghai Chemical Announces Price Increases for All Products
Crude oil prices are strong, and Asian petrochemical products hit hign
Supply and demand status of China's chemical intermediate industry in 2021
Cost and demand support, PTA may continue to run at a high level